Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Ophthalmology
Search Medical Condition
Eye Disease Clinical Trials
A listing of Eye Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (448) clinical trials
ECU-NMO-301: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN PATIENTS WITH RELAPSING NEUROMYELITIS OPTICA (NMO)
Neuromyelitis Optica (NMO) or NMO Spectrum Disorders (NMOSD), also known as Devic’s Disease, is a rare, severe disabling autoimmune inflammatory disorder of the central nervous system (CNS) that predominately affects the optic nerves and spinal cord, and is often characterized by a relapsing course. Throughout this protocol the term NMO ...
A Phase 3, Multi-Center Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy f 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (SEER-1).
The purpose of this study is to compare the safety and efficacy of RGN-259 to placebo for treatment of Neurotrophic Keratopathy (NK).
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDE in Patients with a Chalazion.
This study examines a new vehicle (1.5% Transdermal System TDS) to deliver the study drug to patients who have a Chalazion (a cyst in the eyelid that is caused by a blocked meibomian gland) compared to placebo (TDE).
A Double-Masked, Randomized, Multi-Center Phase I/II Study to Evaluate the Efficacy and Safety of Laripep in Subjects with Dry Eye Associated with Sjögren’s Syndrome
The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep™ ophthalmic solution versus placebo administered 3 times a day for 4 weeks with subjects with Dry Eye associated with Primary Sjögren’s Syndrome
A Washington University research study seeks participants with and without strabismus. (HRPO # 201112051)
This study will look at the effects of strabismus in brain areas that respond to visual stimuli. There are 2 - 5 study visits lasting 1 - 2 hours per visit. Participation includes responding to visual stimuli and MRI scanning (brain imaging). There are no immediate benefits to the participant ...
Project Pinkeye: Red, Crusty, Swollen, Sticky Eyes?
You or your child may be experiencing Bacterial Conjunctivitis, commonly known as Pink eye. To see if you or your child may qualify to take part in a clinical research study of an investigational eye drop compared to placebo (an inactive substance) - contact a participating local physician. Pink Eye ...
A Washington University research study seeks participants with ocular melanoma.
The main purpose of the study is to look at the safety and efficacy of a treatment for ocular melanoma. The study will last about 3 years (1 year of treatment and 2 years of follow up by phone). Participation includes screening procedures including medical history, endoscopy, CT scans, MRI ...
Childhood Atropine for Myopia Progression (CHAMP)
The CHAMP study is designed to evaluate how two different concentrations of an investigational drug called Atropine Sulfate solution compare to placebo drops in slowing down the progression of nearsightedness (myopia) in children.
Do You Have Eye Disease From Shingles?
What is the Zoster Eye Disease Study (ZEDS)? ZEDS is a clinical trial investigating whether long-term treatment with a pill, Valacyclovir, will help reduce eye disease and/or chronic pain in patients with shingles a ecting the eye. Talk to your eye doctor to learn more. ZEDS is funded by the ...
Dry Eye Study
The primary purpose of this study is to determine the efficacy and safety of KPI-121 0.25% ophthalmic suspension compared to vehicle (placebo) in subjects who have a documented clinical diagnosis of dry eye disease. The product will be studied over 14 days, with 1-2 drops instilled in each eye four ...
